USPTO trademark

SUMMIT

Under examinationUSPTOWord and designClass 5

"SUMMIT" is a word and design mark owned by Axsome Therapeutics, Inc., filed at the USPTO on September 2, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Axsome Therapeutics, Inc. portfolioGet this data via the API
Official USPTO record
SUMMIT trademark as filed
As filed with the USPTO
Status
Under examination
Since October 4, 2026
Filed
September 2, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50087185
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns SUMMIT

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Axsome Therapeutics, Inc.

AXSM · New York, United States

150 trademarks in the portfolioView company

Representative

Brent A. Johnson

Procopio, Cory, Hargreaves & Savitch LLP

Goods and services

What the mark covers

The products and services SUMMIT is filed for, grouped by Nice class.

  • Medicated and pharmaceutical preparations for use in connection with smoking cessation; medications for reducing or eliminating smoking and the urge to smoke.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Assigned to examiner
  2. Notice of design search code e-mailed
  3. New application office supplied data entered
  4. Application filing receipt mailed
  5. New application entered
FAQ

About SUMMIT

Who owns the trademark "SUMMIT"?

The USPTO trademark "SUMMIT" (application 50087185) is owned by Axsome Therapeutics, Inc.

What is the status of "SUMMIT"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SUMMIT and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0676a-ada3-73ea-987b-987afdf68d57
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0676a-ada3-73ea-987b-987afdf68d57",
  "object": "trademark",
  "mark_text": "SUMMIT",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50087185",
  "filing_date": "2026-09-02",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Axsome Therapeutics, Inc.",
      "entity_id": "ent_019ebba6-3220-71b6-8fee-f721d26ca090"
    }
  ]
}